These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8595788)

  • 21. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.
    Morimoto K; Sato H; Yamamoto Y; Watanabe T; Suwaki H
    Epilepsia; 1997 Sep; 38(9):966-74. PubMed ID: 9579934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the antiepileptic drug tiagabine.
    Schachter SC
    Clin Neuropharmacol; 1999; 22(6):312-7. PubMed ID: 10626090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety of tiagabine.
    Kälviäinen R
    Epilepsia; 2001; 42 Suppl 3():46-8. PubMed ID: 11520323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of tiagabine monotherapy on abilities, adjustment, and mood.
    Dodrill CB; Arnett JL; Shu V; Pixton GC; Lenz GT; Sommerville KW
    Epilepsia; 1998 Jan; 39(1):33-42. PubMed ID: 9578010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and EEG findings in six patients with altered mental status receiving tiagabine therapy.
    de Borchgrave V; Lienard F; Willemart T; van Rijckevorsel K
    Epilepsy Behav; 2003 Jun; 4(3):326-37. PubMed ID: 12791336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.
    Kälviäinen R
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epilepsy in the elderly: the use of tiagabine.
    Pedersen B
    Epilepsia; 2001; 42 Suppl 3():52-4. PubMed ID: 11520325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of tiagabine: summary of 53 trials.
    Leppik IE; Gram L; Deaton R; Sommerville KW
    Epilepsy Res; 1999 Feb; 33(2-3):235-46. PubMed ID: 10094434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiagabine.
    Mengel H
    Epilepsia; 1994; 35 Suppl 5():S81-4. PubMed ID: 8039477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between tiagabine and conventional antiepileptic drugs in the rat model of complex partial seizures.
    Borowicz KK; Zadrozniak M; Luszczki JJ; Czuczwar SJ
    J Neural Transm (Vienna); 2008 May; 115(5):661-7. PubMed ID: 18193378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiagabine as add-on therapy may be more effective with valproic acid--open label, multicentre study of patients with focal epilepsy.
    Jedrzejczak J
    Eur J Neurol; 2005 Mar; 12(3):176-80. PubMed ID: 15693805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New antiepileptic drugs: comparison of key clinical trials.
    Cramer JA; Fisher R; Ben-Menachem E; French J; Mattson RH
    Epilepsia; 1999 May; 40(5):590-600. PubMed ID: 10386528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and EEG findings in complex partial status epilepticus with tiagabine.
    Trinka E; Moroder T; Nagler M; Staffen W; Löscher W; Ladurner G
    Seizure; 1999 Feb; 8(1):41-4. PubMed ID: 10091848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient dystonias in three patients treated with tiagabine.
    Wolańczyk T; Grabowska-Grzyb A
    Epilepsia; 2001 Jul; 42(7):944-6. PubMed ID: 11488897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials?
    Somerville ER
    Neurology; 2002 Jul; 59(1):79-83. PubMed ID: 12105311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population analysis of the pharmacokinetics of tiagabine in patients with epilepsy.
    Samara EE; Gustavson LE; El-Shourbagy T; Locke C; Granneman GR; Sommerville KW
    Epilepsia; 1998 Aug; 39(8):868-73. PubMed ID: 9701378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-convulsive status epilepticus associated with tiagabine in a pediatric patient.
    Mangano S; Cusumano L; Fontana A
    Brain Dev; 2003 Oct; 25(7):518-21. PubMed ID: 13129597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor.
    Suzdak PD; Jansen JA
    Epilepsia; 1995 Jun; 36(6):612-26. PubMed ID: 7555976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tiagabine in glial tumors.
    Striano S; Striano P; Boccella P; Nocerino C; Bilo L
    Epilepsy Res; 2002 Mar; 49(1):81-5. PubMed ID: 11948010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.